News Releases

Albert Einstein College of Medicine Receives $16 Million NIH Grant to Study Cellular Process Linked to Alzheimer’s Disease
Einstein Welcomes New Class of Medical Students and Introduces Innovative Curriculum Changes
NIH Delivers $4.3 Million to Support Convalescent Plasma Clinical Trial

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Elyse S. Sussman

Elyse S. Sussman, Ph.D.

Area(s) of expertise: Autism/learning disabilitiesAttention deficit hyperactivity disorder (ADHD)Language development/language impairment

Dr. Sussman studies auditory scene perception, a crucial hearing skill that allows us to follow a single voice in a crowded room. Her research focuses on understanding how auditory cognition changes across the… Learn more

Einstein in the News

Researchers Learning More About How the Coronavirus Sabotages Blood Vessels

Gaetano Santulli, M.D., Ph.D., comments on the damage caused by COVID-19 to the cells that line blood vessels and the resulting increased risk of blood clots throughout the body. Dr. Santulli is assistant professor of medicine and of molecular pharmacology.

Apathy Could Lead to a Greater Risk of Dementia, Study Finds

Joe Verghese, M.B.B.S., M.S., comments on a study that found apathy in older adults could be a risk factor for dementia and notes his prior research suggests that addressing apathy could help delay the onset of dementia. Dr. Verghese is chief of geriatrics at Einstein and Montefiore and director of the Montefiore Einstein Center for the Aging Brain.

More coverage on Dr. Verghese

The New York Times
The Race for a Super-Antibody Against the Coronavirus

Kartik Chandran, Ph.D., describes the efforts of a multi-institutional collaboration he is leading to discover a potent, long-lasting antibody that would be effective against a range of coronaviruses, not only the one that causes COVID-19. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.

More coverage on Dr. Chandran


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog